for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Fate Therapeutics Announces FDA Clearance Of Ind Application For First-Ever Ipsc-Derived Car T-Cell Therapy

Fate Therapeutics Inc:

* FATE THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR FIRST-EVER IPSC-DERIVED CAR T-CELL THERAPY

* FATE THERAPEUTICS INC - PHASE 1 CLINICAL STUDY WILL EVALUATE FT819 FOR PATIENTS WITH ADVANCED B-CELL LEUKEMIAS AND LYMPHOMAS Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up